Processa Pharmaceuticals Financial Overview
Processa Pharmaceuticals's market cap is currently $17.42M. The company's EPS TTM is $-0.07; its P/E ratio is -0.15; Processa Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
